Evaluation of Urolithin A and Fisetin on Improving Sleep and Aging Biomarkers — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Evaluation of Urolithin A and Fisetin on Improving Sleep and Aging Biomarkers — Stella

Recruiting

Back to Sleep Disorder trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

China

Wuchang Hospital Affiliated to Wuhan University of Science and Technology, Wuhan, Hubei

Key details

Sponsor

Huazhong University of Science and Technology

Collaborators

Wuhan Wuchang Hospital, Abinopharm, Inc

Enrollment target

~80 participants

Started

September 2025

Primary completion

May 2026

Age range

30 Years – 75 Years

Last updated January 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov